Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01158742 · ClinicalTrials.gov registry record

Live Kidney Donor Study -Renal Function Study

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
402
Enrollment target

NCT01158742: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT01158742 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 402 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01158742 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
402 participants
Enrollment target

Study Summary

Kidney transplantation from living donors has been shown to carry many benefits over deceased donor transplantation. Because of benefits such as shorter waiting times and improved outcome for transplant recipients, living kidney donation accounts for an increasing number of kidney transplants nationwide. Most published studies about living kidney donation demonstrate that the procedure is safe, but they also emphasize concerns that long-term data on live donor outcomes are insufficient. In particular, data concerning the extent of renal function decline after donation are inadequate. This study will measure glomerular filtration rate (GFR) in previous living donors and aims to more accurately describe renal function after kidney donation.

Interventions

  • OTHER Glomerular Filtration Rate with Iothalamate
  • OTHER Glomerular Filtration Rate with Iohexol

Trial Details

FieldValue
Enrollment Target 402 participants
Start Date 2009-09
Est. Completion 2012-06

What the finished NCT01158742 record still lists

NCT01158742 is an observational study that tracks outcomes without assigning an intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Glomerular Filtration Rate with Iothalamate is the first listed.

NCT01158742 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01158742 about?

NCT01158742 is a clinical study titled "Live Kidney Donor Study -Renal Function Study". Kidney transplantation from living donors has been shown to carry many benefits over deceased donor transplantation. Because of benefits such as shorter waiting times and improved outcome for transplant recipients, living kidney donation accounts for an increasing number of kidney transplants nation...

What is the current status of trial NCT01158742?

This trial is currently completed. The enrollment target is 402 participants. The study started on 2009-09. Estimated completion is 2012-06.

What interventions are being tested in trial NCT01158742?

The interventions under investigation include: Glomerular Filtration Rate with Iothalamate (OTHER), Glomerular Filtration Rate with Iohexol (OTHER).

Who is sponsoring clinical trial NCT01158742?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04464226 · 402 participants · Phase 3

    Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

  • NCT05183763 · 402 participants · NA

    Medication Adherence Program

  • NCT06748222 · 402 participants · Phase 3

    E-Mindfulness Approaches for Living After Breast Cancer

  • NCT06896474 · 402 participants · NA

    SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01158742, the US trial registry maintained by the National Library of Medicine. NCT01158742 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.